(Q35803122)

10 August 2017

The induction effect of rifampicin on activity of mephenytoin 4'-hydroxylase related to M1 mutation of CYP2C19 and gene dose (English)

1 reference

10 August 2017

1 reference

H J Feng

1

1 reference

10 August 2017

S L Huang

series ordinal

2

1 reference

10 August 2017

W Wang

series ordinal

3

1 reference

10 August 2017

H H Zhou

series ordinal

4

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 January 1998

1 reference

British Journal of Clinical Pharmacology

10 August 2017

1 reference

10 August 2017

45

1 reference

10 August 2017

1

1 reference

10 August 2017

27-29

1 reference

The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873992

Evidence that CYP2C19 is the major (S)-mephenytoin 4'-hydroxylase in humans

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873992

Biochemistry and molecular biology of the human CYP2C subfamily

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873992

Mephenytoin hydroxylation deficiency: kinetics after repeated doses

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873992

Enzyme induction and beta-adrenergic receptor blocking drugs

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873992

Family studies of mephenytoin hydroxylation deficiency

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873992

S-mephenytoin 4-hydroxylase is inherited as an autosomal-recessive trait in Japanese families

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873992

Induction of polymorphic 4'-hydroxylation of S-mephenytoin by rifampicin

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873992

Debrisoquine/sparteine hydroxylation genotype and phenotype: analysis of common mutations and alleles of CYP2D6 in a European population

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873992

Update on rifampin drug interactions. II.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873992

Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873992

High-performance liquid chromatographic determination of urinary 4'-hydroxymephenytoin, a metabolic marker for the hepatic enzyme CYP2C19, in humans

25 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/9489590

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Genetic analysis of the S-mephenytoin polymorphism in a chinese population*

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/9489590

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1046/J.1365-2125.1998.00643.X

1 reference

10 August 2017

1 reference

10 August 2017

PubMed publication ID

9489590

1 reference